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ABSTRACT Binding of cell surface glycans by inﬂuenza hemagglutinin controls viral attachment and infection of host cells. This
binding is a three-way interaction between viral proteins, host glycans, and viral glycans; many structural details of this interaction
have been difﬁcult to resolve. Here, we use a series of 100-ns molecular dynamics simulations to further analyze available
crystallographicdataonhemagglutinin-ligand interactions.Basedonoursimulations,wepredict that the viral glycanscontact thehost
glycanswithin 1–2 residues of the ligand-binding site.We also predict that the glycan-glycan interactions contain both stabilizing and
destabilizing components. These predictions suggest a structural means to explain why changes to viral glycosylation alter the
efﬁciency and selectivity of ligand binding. We also predict that the proximity of these interactions to the ligand-binding pocket will
impact the binding afﬁnity of small glycomimetic ligands analogous to the inﬂuenza neuraminidase inhibitors currently in clinical use.
Received for publication 6 July 2008 and in ﬁnal form 17 July 2008.
Address reprint requests and inquiries to Vijay Pande, E-mail: pande@stanford.edu.
Inﬂuenza hemagglutinin binds host cell glycans to mediate
viral attachment and ultimately entry into cells. Hemagglutinin
itself is heavily glycosylated (1), and changes in viral glyco-
sylation alter the speciﬁcity and efﬁciency of host-cell attach-
ment (2–4), but the structural basis for this remains unknown. It
is also unknown whether the glycan-ligand interaction occurs
close to the ligand-binding site on the protein or distal to it. The
speciﬁcity of ligand binding and cell attachment by inﬂuenza is
challenging topredict because it involves a complex interaction
between hemagglutinin on the virion surface, multivalent
target-cell glycans, and glycans covalently attached to hemag-
glutinin.
Altering any of these three components can affect efﬁciency
of infection (2–6). Modiﬁcation of viral glycans by producing
inﬂuenza in different host cell types has been shown to alter
efﬁciency and speciﬁcity of infection in different target cell
types. Truncation of viral glycans near the ligand-binding site
has a complex effect: truncation of fowl plague virus glycans
increased viral binding to host receptors, while deletion of
similarly located glycans in human H1N1 inﬂuenza decreased
binding to a-2,6 sialyllactose ligands but did not change
binding to a-2,3 ligands. These differences are particularly
important for considering interspecies transmission of inﬂu-
enza; hemagglutinin glycosylation varies with host cell type,
and the cells that inﬂuenza infects in the human upper
respiratory tract, the human lower respiratory tract, and the
avian respiratory tract can be differentiated based on expres-
sion of a-2,6 vs. a-2,3 sialyllactose-containing glycans (7–9).
A structural explanation for these biochemical data is
challenging because only a subset of the viral glycans have
been resolvable via x-ray crystallography, and the ligands used
in structural studies represent a fragment of the cell-surface
receptors in the respiratory tract. Even those short fragments are
quite ﬂexible and have been difﬁcult to resolve in many
crystallographic datasets (10,11). It therefore remains un-
known whether glycan-glycan interaction occurs near the
protein-binding pocket andwhethermotions of the viral glycan
affect binding pocket conformation. Molecular dynamics sim-
ulations provide a means to analyze this glycoprotein ﬂexibility
using existing structures as a starting point. In this report, we use
a seriesof100-nsmolecular dynamics simulations to investigate
the interaction between viral glycans of differing length, host
ligands, and the hemagglutinin protein. Our analysis suggests
that viral glycans contact the host ligandswithin 1–2 residues of
the terminal sialic acid and thereforemay affect binding near the
binding pocket rather than distant from it.
We have simulated the binding of trisaccharide ligands by
hemagglutinin with two different glycosylation patterns: a core
sequence comprising only those residues that were crystallo-
graphically ordered (1,10) and a longer full glycan detected in
mammalian cell culture at the N165 site (see Scheme 1 in
Supplementary Material, Data S1) (12,13). Crystal structures
ofA/Aichi/68H3N2hemagglutininbound toa2,3-sialyllactose
(10) formed the starting point for all simulations. Each
simulation was run for 100 ns using GROMACS 4 and the
AMBER03 and GLYCAM force ﬁelds (14–16); see support-
ing information for additional details.
Glycan and protein motion was measured by scoring
residues in the hemagglutinin-ligand complex using root
mean-squared ﬂuctuation (RMSF) during the simulation.
The protein as a whole did not substantially drift from the
crystal structure (RMSF 1.9 A˚), and RMSF values show
agreement with crystallographic B-factors (Fig. S1 in Data
S1). Consistent with their crystallographically ordered state,
the core glycans maintain a relatively stable conformation
throughout the simulation. RMSF values for core glycans at
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the N165 glycosylation site were 1.9 A˚, compared with 1.4 A˚
for protein residues in the binding pocket. Glycans at other
sites did not interact with the ligand in our simulations. The
Gal2 and Glc3 residues of the ligand display increased
ﬂexibility, with RMSF values of 2.2 and 4.0 A˚ for Gal2 and
Glc3, respectively, after rigid-body alignment to the sialic
acid positions (91st and 98th percentiles among all residues
in the complex). Simulations of hemagglutinin with longer
glycan chains show greater ﬂexibility in the distal residues;
RMSF values are given in Tables S1–S2 in Data S1.
This predicted glycan ﬂexibility allows additional contacts
between the ligand and the glycoprotein beyond those vis-
ualized in the crystal structure. We therefore assess each con-
tact by the fractionof simulation snapshots inwhich it is present
rather than using a single static structure (Fig. 1, and Fig. S2 in
DataS1).As shown inFig. 2,a andd, the binding pocket for the
terminal sialic acid is relatively stable in our simulations and is
composed almost entirely of protein residues.
The proximal D-galactose residue (Gal2) of the ligand has
a much more diverse set of interactions, with many residues
contacting but few in constant contact (Fig. 2, b and e). The
core viral glycan residues contact Gal2 in up to 20% of
snapshots. This more broadly distributed contact histogram
suggests the importance of dynamic heterogeneity in
hemagglutinin-ligand interactions.
The distal D-glucose (Glc3) of the ligand shows a similarly
diverse set of interactions, but it interacts much more
strongly with the core glycan sequences (up to 40% of
simulation time (Fig. 2, c and f). Similar results were
obtained from simulations of the longer full glycans (Figs.
S3 and S4 in Data S1). These simulation data suggest that the
viral glycans contact the host glycan extensively within two
residues of the terminal sialic acid. The diversity of contacts
also argues that multiple structures are required to best
explain the effect of viral glycosylation on ligand binding.
In addition to estimating equilibrium contact frequency (a
value analogous to KD), we performed kinetic analysis of the
simulation data to estimate contact dissociation timescales. In
our simulations, some contacts between ligand and glyco-
protein were transient, while others were much longer-
lived—we quantitate this via autocorrelation functions for
each contact. Analysis of the time autocorrelation functions
(Fig. S5 in Data S1) for glycan-ligand contacts shows that 40–
50% of encounters are transient in our simulations, decaying
with time constant t of 0.05–0.09 ns. The remaining;50%of
encounters result in more stable association between viral
glycans and ligand (t 26–56 ns). This slowed decay suggests
an energetically favorable interaction. While each individual
glycan-glycan contact is relatively short-lived on experimen-
tal timescales, repeated encounters may stabilize the overall
hemagglutinin-ligand interaction.
These simulation results have several important conse-
quences for understanding the interaction between the cell
type in which inﬂuenza virus was grown and the cell type
that it will infect. Our simulations extend the available
crystallographic information to help explain functional and
biochemical data in this regard. Based on our simulations,
we predict that: 1), many viral glycan-host glycan interac-
tions occur within 1–2 residues of the terminal sialic acid;
and 2), these interactions may include steric or entropic
penalties of ligand binding and energetically favorable
contacts that stabilize binding. Truncation of H1N1 inﬂuenza
glycans showed a differential effect on binding of a-2,3 vs.
a-2,6-linked glycans (3); our simulations suggest that this
effect, if present in H3N2 hemagglutinin, is detectable using
trisaccharide ligands. Simulations are now underway to
compare a-2,3 and a-2,6 sialyllactose in complex with
hemagglutinin bearing either truncated glycans or the full
sequence; these simulations enable speciﬁc prediction of
glycan effects on experimental binding assays.
The DDG of ligand binding as the length of the viral
glycan extends depends on three main factors: an increased
entropic penalty from the restriction of glycan conﬁgura-
tional entropy, the change in binding energy from favorable
glycan-ligand interactions, and a possible enthalpic penalty
FIGURE 1 Ligand-binding pocket for core glycan simulations.
Atomswith contact frequency >10% are rendered in surface form
and colored by contact frequency. A single binding pocket is
enlarged in the inset.
FIGURE 2 Distribution of glycan-ligand contacts by ligand
residue. (a–c) Contact frequency histograms between the ligand
and all glycoprotein atoms. (d–f) Histograms for contact between
ligand and viral glycans only.
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if ligand binding increases the occupancy of high-energy
glycan conformations. Accurately estimating these quantities
requires extensive sampling to estimate the relative proba-
bilities of different conformations. Future work will utilize
methods such as free-energy perturbation to quantitatively
predict the effects of glycan length on ligand-binding afﬁnity
and speciﬁcity.
TheAichi/2/68 strain usedhere is the earliest isolate from the
1968 epidemic that marked the emergence of H3N2 inﬂuenza
in humans. While the 1968 epidemic was relatively mild com-
pared with 1918, it nonetheless serves as a model for a newly
emergent inﬂuenza subtype. At such times, existing vaccines
may be of little use and effective antivirals thus particularly
helpful in therapy.Moreover, theAichi isolate binds botha-2,3
and a-2,6 sialyllactose in solution (KD of 3.2 and 2.1 mM,
respectively (10)) and binds a-2,3 gangliosides in plate-based
assays (17). Since the biochemical data for H1N1 suggest that
changes to hemagglutinin glycosylation affect the binding of
these two ligands differently, a hemagglutinin that binds both
ligands (and may be somewhat intermediate between avian-
and human-adapted forms) is of particular interest.
While biochemical data have shown that the process of
ligand binding by inﬂuenza hemagglutinin depends on both
ligand-protein interactions and ligand-glycan interactions,
they do not demonstrate whether these two sets of interac-
tions are coupled. Our results suggest that ligand-glycan
interaction can occur quite close to the sialic-acid-binding
site and thus any conformational bias induced by the glycan
could affect protein-ligand interactions. We therefore predict
that the ligand-protein and ligand-glycan interactions are
coupled rather than completely separable.
Our predictions carry particular importance for the design
of glycomimetic ligands for hemagglutinin, including
inhibitors analogous to the neuraminidase inhibitors cur-
rently in clinical use. If viral glycan-host glycan interactions
occurred distant from the sialic-acid binding site, viral
glycosylation would affect ligand binding in a manner
independent from small-molecule binding. Since we predict
that contact can occur close to the sialic acid site, however,
viral glycosylation and glycan motion can have a substantial
effect on small-molecule binding.
SUPPLEMENTARY MATERIAL
To view all of the supplemental ﬁles associated with this
article, visit www.biophysj.org.
ACKNOWLEDGMENTS
The authors thank K. Branson, V. Voelz, R. Brandman, and A. Laederach
for many helpful discussions and National Science Foundation award No.
CNS-0619926 for computer resources.
P.M.K. was supported by a fellowship from the Berry Foundation. This
work was also supported by the National Science Foundation Center on
Polymer Interfaces and Macromolecular Assemblies, and dissemination
support was provided by the National Institutes of Health SimBIOS Center.
REFERENCES and FOOTNOTES
1. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the
hemagglutinin membrane glycoprotein of inﬂuenza virus at 3 A˚
resolution. Nature. 289:366–373.
2. Marinina, V. P., A. S. Gambarian, N. V. Bovin, A. B. Tuzikov, A. A.
Shilov, B. V. Sinitsyn, and M. N. Matrosovich. 2003. Mol. Biol.
(Mosk.). [The effect of losing glycosylation sites near the receptor-
binding region on the receptor phenotype of the human inﬂuenza virus
H1N1]. 37:550–555.
3. Gambaryan, A. S., V. P. Marinina, A. B. Tuzikov, N. V. Bovin, I. A.
Rudneva, B. V. Sinitsyn, A. A. Shilov, and M. N. Matrosovich. 1998.
Effects of host-dependent glycosylation of hemagglutinin on receptor-
binding properties of H1N1 human inﬂuenza A virus grown in MDCK
cells and in embryonated eggs. Virology. 247:170–177.
4. Ohuchi, M., R. Ohuchi, A. Feldmann, and H. D. Klenk. 1997.
Regulation of receptor binding afﬁnity of inﬂuenza virus hemagglutinin
by its carbohydrate moiety. J. Virol. 71:8377–8384.
5. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane
fusion in virus entry: the inﬂuenza hemagglutinin. Annu. Rev. Biochem.
69:531–569.
6. Yamada, S., Y. Suzuki, T. Suzuki, M. Q. Le, C. A. Nidom, Y. Sakai-
Tagawa, Y. Muramoto, M. Ito, M. Kiso, T. Horimoto, K. Shinya, T.
Sawada, M. Kiso, T. Usui, T. Murata, Y. Lin, A. Hay, L. F. Haire, D. J.
Stevens, R. J. Russell, S. J. Gamblin, J. J. Skehel, and Y. Kawaoka.
2006. Hemagglutinin mutations responsible for the binding of H5N1
inﬂuenza A viruses to human-type receptors. Nature. 444:378–382.
7. Shinya, K., M. Ebina, S. Yamada, M. Ono, N. Kasai, and Y. Kawaoka.
2006. Avian ﬂu: inﬂuenza virus receptors in the human airway. Nature.
440:435–436.
8. van Riel, D., V. J. Munster, E. de Wit, G. F. Rimmelzwaan, R. A.
Fouchier, A. D. Osterhaus, and T. Kuiken. 2006. H5N1 Virus
attachment to lower respiratory tract. Science. 312:399.
9. van Riel, D., V. J. Munster, E. de Wit, G. F. Rimmelzwaan, R. A.
Fouchier, A. D. Osterhaus, and T. Kuiken. 2007. Human and avian
inﬂuenza viruses target different cells in the lower respiratory tract of
humans and other mammals. Am. J. Pathol. 171:1215–1223.
10. Sauter, N. K., J. E. Hanson, G. D. Glick, J. H. Brown, R. L. Crowther, S.
Park, J. J. Skehel, and D. C. Wiley. 1992. Binding of inﬂuenza virus
hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis
by proton nuclear magnetic resonance spectroscopy and x-ray crystal-
lography. Biochemistry. 31:9609–9621.
11. Eisen, M. B., S. Sabesan, J. J. Skehel, and D. C. Wiley. 1997. Binding
of the inﬂuenza A virus to cell-surface receptors: structures of ﬁve
hemagglutinin-sialyloligosaccharide complexes determined by x-ray
crystallography. Virology. 232:19–31.
12. Mir-Shekari, S. Y., D. A. Ashford, D. J. Harvey, R. A. Dwek, and I. T.
Schulze. 1997. The glycosylation of the inﬂuenza A virus hemagglutinin
bymammalian cells. A site-speciﬁc study. J. Biol. Chem. 272:4027–4036.
13. Kuroda, K., H. Geyer, R. Geyer, W. Doerﬂer, and H. D. Klenk. 1990.
The oligosaccharides of inﬂuenza virus hemagglutinin expressed in
insect cells by a baculovirus vector. Virology. 174:418–429.
14. Hess, B., C. Kutzner, D. van der Spoel, and E. Lindahl. 2008.
GROMACS 4: algorithms for highly efﬁcient, load-balanced, and
scalable molecular simulation. J. Chem. Theory Comput. 4:435–447.
15. Kirschner, K. N., A. B. Yongye, S. M. Tschampel, and J. Gonzalez-
Outeirin˜o. 2007. GLYCAM06: a generalizable biomolecular force ﬁeld.
Carbohydrates. J. Comput. Chem. 29:622–655.
16. Duan, Y., C. Wu, S. Chowdhury, M. C. Lee, G. Xiong, W. Zhang, R.
Yang, P. Cieplak, R. Luo, T. Lee, J. Caldwell, J. Wang, and P. Kollman.
2003. A point-charge force ﬁeld for molecular mechanics simulations
of proteins based on condensed-phase quantum mechanical calcula-
tions. J. Comput. Chem. 24:1999–2012.
17. Matrosovich, M. N., A. S. Gambaryan, S. Teneberg, V. E. Piskarev,
S. S. Yamnikova, D. K. Lvov, J. S. Robertson, and K. A. Karlsson.
1997. Avian inﬂuenza A viruses differ from human viruses by recogni-
tion of sialyloligosaccharides and gangliosides and by a higher con-
servation of the HA receptor-binding site. Virology. 233:224–234.
Biophysical Journal: Biophysical Letters L50
Biophysical Journal: Biophysical Letters
